Compounding Pharmacy · Ocala, FL · Both

Wells Pharmacy Network Review

Wells Pharmacy Network is a compounding pharmacy network that operates a 503A pharmacy in Ocala, Florida and an FDA-registered 503B outsourcing facility in Dyersburg, Tennessee. Focuses on wellness, weight management, and hormone compounding. FDA issued Form 483s to the Dyersburg 503B in April 2025 and April 2026 and untitled letters in 2022 and 2025.

Wells Pharmacy Network is a different company from Wells Pharma of Houston, a separate 503B that received its own FDA warning letter in November 2025. The network's Dyersburg, Tennessee outsourcing site has drawn FDA untitled letters in 2022 and October 2025 and Form 483s in April 2025 and April 2026. Eden names Wells among the pharmacies it uses.

7 FDA, state or legal actions on record. Most recent: FDA Form 483 (Apr 9, 2026) — see the full record below.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

BothPCAB
Location: Ocala, FL
Website: wellsrx.com
7.9/10
★★★★☆4/5

Editorial score out of 10 · methodology

Regulatory Actions

FDA Warning Letter issued to Wells Pharmacy Network LLC citing serious deficiencies in sterile drug production practices. Source: Quackwatch archive of FDA letter.
FDA Form 483 issued to Wells Pharmacy Network LLC, Ocala FL, following inspection. Observations included use of non-pharmaceutical-grade materials in drug preparation. Source: FDA.
FDA FMD-145 letter issued to the Ocala, FL 503A facility.
FDA Untitled Letter issued to the Dyersburg, TN 503B facility.
FDA Form 483 issued to the Dyersburg, TN 503B facility.
FDA Untitled Letter issued to the Dyersburg, TN 503B facility.
FDA Form 483 issued to Wells Pharmacy Network LLC, Dyersburg, TN 503B facility.

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Wells Pharmacy Network. Sourcing arrangements can change over time.

7.2/ 10
Partner

Eden

Best for: compounded semaglutide or tirzepatide at one flat monthly price that doesn't rise with your dose

★★★★☆3.6/5

Editorial score · methodology

$99/mosemaglutide
$129/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneFDA Warning
Get StartedRead full Eden review →
7.2/ 10

EverPrime

Best for: compounded GLP-1 care with labs and provider visits included, from the company behind Enhance MD

★★★★☆3.6/5

Editorial score · methodology

$249/4 wkssemaglutide
billed per 4 weeks
$329/4 wkstirzepatide
billed per 4 weeks
SemaglutideTirzepatideGlutathioneNAD+

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Wells Pharmacy Network has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

External Reviews

Google Reviews
3.7 / 5.0
Based on 65 reviews

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing5/10
State CoverageNot published
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Low confidence · Pharmacy details last verified November 2026 · How we verify provider data

Frequently Asked Questions

Wells Pharmacy Network is a Both compounding pharmacy based in Ocala, FL. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. Note: our records show 7 documented regulatory action(s) — see the Regulatory Actions section below.
Wells Pharmacy Network is headquartered in Ocala, FL. It has not published a state-by-state licensure list, so verify licensure for your state with your state board of pharmacy.
Wells Pharmacy Network produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a Both pharmacy, it operates both a patient-specific 503A division and an FDA-registered 503B outsourcing facility.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology (as of November 2026)
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.